refractory childhood acute lymphoblastic leukemia

Showing 1 - 4 of 4

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

Recruiting
  • Recurrent Childhood Acute Myeloid Leukemia
  • +17 more
    • Miami, Florida
      Nicklaus Children's Hospital
    May 13, 2023

    Ex Vivo Drug Sensitivity Testing and Mutation Profiling

    Completed
    • Recurrent Childhood Acute Myeloid Leukemia
    • +13 more
      • Miami, Florida
        Nicklaus Children's Hospital
      Jan 18, 2023

      B Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia, Refractory Childhood Acute Lymphoblastic

      Completed
      • B Acute Lymphoblastic Leukemia
      • +3 more
      • AUTO3 (CD19/22 CAR T cells
      • London, United Kingdom
      • +2 more
      Jan 11, 2021

      B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent

      Terminated
      • B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1
      • +4 more
      • Chicago, Illinois
        Northwestern University
      Jan 31, 2020